» Articles » PMID: 26215836

Association of Nicotinamide-N-Methyltransferase Gene Rs694539 Variant with Epilepsy

Overview
Journal Mol Neurobiol
Date 2015 Jul 29
PMID 26215836
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Here, we report the association of the rs694539 variant of nicotinamide-N-methyltransferase gene with epilepsy in a case-control study of 215 patients with epilepsy and 239 healthy controls (χ (2) = 11.641, P = 0.003). The individuals with the GG genotype revealed protection against epilepsy (χ (2) = 5.866, P = 0.015, OR = 0.623, 95 % CI = 0.425-0.915), whereas the individuals with the AA genotype showed statistically significant increased risk for epilepsy (χ (2) = 8.676, P = 0.003, OR = 5.479, 95 % CI = 1.553-19.337). In addition, the G allele was protective against epilepsy (χ (2) = 8.676, P = 0.003, OR = 0.183, 95 % CI = 0.052-0.644); on the contrary, the A allele was a genetic risk factor for epilepsy (χ (2) = 5.866, P = 0.015, OR = 1.604, 95 % CI = 1.093-2.354). Stratification analysis revealed that the association was statistically significant in male patients with epilepsy (χ (2) = 6.682, P = 0.035). However, the statistical power was only 0.33 in female patients with epilepsy (χ (2) = 5.275, P = 0.072). This finding, for the first time, suggests the involvement of the NNMT gene rs694539 variant in the etiology of epilepsy.

Citing Articles

Exploring NNMT: from metabolic pathways to therapeutic targets.

Park J, Shin E, Kim T, Yang J, Ki S, Kang K Arch Pharm Res. 2024; 47(12):893-913.

PMID: 39604638 DOI: 10.1007/s12272-024-01519-9.


Nicotinamide N-Methyltransferase (NNMT): A New Hope for Treating Aging and Age-Related Conditions.

Li J, Sun W, Zhu X, Mei Y, Li W, Li J Metabolites. 2024; 14(6).

PMID: 38921477 PMC: 11205546. DOI: 10.3390/metabo14060343.


Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms.

Li J, Sun C, Cai W, Li J, Rosen B, Chen J Mutat Res Rev Mutat Res. 2021; 788:108396.

PMID: 34893161 PMC: 8847900. DOI: 10.1016/j.mrrev.2021.108396.


Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes.

Liu J, Deng Z, Zhu X, Zeng Y, Guan X, Li J Biomed Res Int. 2021; 2021:9924314.

PMID: 34368359 PMC: 8337113. DOI: 10.1155/2021/9924314.


Nicotinamide -Methyltransferase: Genomic Connection to Disease.

Ramsden D, Waring R, Parsons R, Barlow D, Williams A Int J Tryptophan Res. 2020; 13:1178646920919770.

PMID: 32547055 PMC: 7273554. DOI: 10.1177/1178646920919770.


References
1.
Kara I, Sazci A, Ergul E, Kaya G, Kilic G . Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res. 2003; 111(1-2):84-90. DOI: 10.1016/s0169-328x(02)00672-1. View

2.
Sazci A, Ergul E, Guzelhan Y, Kaya G, Kara I . Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia. Brain Res Mol Brain Res. 2003; 117(1):104-7. DOI: 10.1016/s0169-328x(03)00327-9. View

3.
Carr D, Whiteley G, Alfirevic A, Pirmohamed M . Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review. Pharmacogenomics J. 2009; 9(5):291-305. DOI: 10.1038/tpj.2009.29. View

4.
Sazci A, Ozel M, Ergul E, Onder M . Association of nicotinamide-N-methyltransferase (NNMT) gene rs694539 variant with bipolar disorder. Gene. 2013; 532(2):272-5. DOI: 10.1016/j.gene.2013.08.077. View

5.
Bhalla D, Godet B, Druet-Cabanac M, Preux P . Etiologies of epilepsy: a comprehensive review. Expert Rev Neurother. 2011; 11(6):861-76. DOI: 10.1586/ern.11.51. View